USPTO serial 90050163
POLYSTART
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- GUROK, GALINA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with POLYSTART?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James Namiki
JAMES NAMIKI DWC LAW FIRM, P.S.PO BOX 3041SEATTLE, WA 98114UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chimeric nucleic acid and nucleic acid molecules for scientific use, namely, research and development use and for use in the manufacture of pharmaceuticals; chimeric nucleic acid and nucleic acid molecules for use in the manufacture of recombinant nucleic acids and recombinant polypeptides/proteins/antigenic determinants encoded thereby | ACTIVE | — |
| 005 | chimeric nucleic acid vector delivery systems administered in vivo or ex vivo to evaluate or elevate the expression of an encoded polypeptide or selected antigenic epitopes for medical purposes; chimeric nucleic acid administered in vivo or ex vivo to evaluate or elevate the expression of an encoded polypeptide or selected antigenic epitopes for medical purposes; chimeric nucleic acid-based immunotherapeutic and immunoprophylactic vaccines for the treatment of cancer and infectious disease; vaccine adjuvants | ACTIVE | — |
| 042 | Medical and scientific research and development services in the field of vaccine technology specific to oncology or infectious diseases; Medical and scientific research and development services in the field of vaccine technology; Medical and scientific research and development services in the fields of nucleic acid expression technology, and evaluation of expressed protein, polypeptide, or antigenic epitopes; consulting services in the field of protein expression, vaccine technology, and the elevation of the expression of selected proteins, polypeptides and antigenic epitopes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MARKER THERAPEUTICS, INC.
- Other trademarks owned by MARKER THERAPEUTICS, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named POLYSTART
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 30, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 30, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 26, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 1, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 1, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 11, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 23, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 22, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 12, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 16, 2020 | NWAP | NEW APPLICATION ENTERED | — |